The gain of hydrogen peroxide resistance benefits growth fitness in mycobacteria under stress

Protein and Cell

Volumn 5, Issue 3, 2014, Pages 182-185

  Li, Xiaojing ^a,b   Tao, Jun ^a   Han, Jiao ^a   Hu, Xinling ^a   Chen, Yuling ^c   Deng, Haiteng ^c   Zhang, Guangchun ^d   Hu, Xiaoxiang ^d   Mi, Kaixia ^a,e  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c TSINGHUA UNIVERSITY   (China)

^d CHINA AGRICULTURAL UNIVERSITY   (China)

^e Beijing Key Laboratory of Microbial Drug Resistance and Resistome   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; ISONIAZID; REACTIVE OXYGEN METABOLITE;

ANTIBIOTIC RESISTANCE; BACTERIAL GROWTH; DNA DAMAGE; DRUG DETOXIFICATION; ELECTROPORATION; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; LETTER; MACROPHAGE ACTIVATION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MUTAGEN TESTING; MUTATION RATE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSPOSON;

CORYNEBACTERINEAE;

AMINO ACID SEQUENCE; GENES, BACTERIAL; HYDROGEN PEROXIDE; MOLECULAR SEQUENCE DATA; MUTATION; MYCOBACTERIUM; PEPTIDES; STRESS, PHYSIOLOGICAL;

EID: 84898600326     PISSN: 1674800X     EISSN: 16748018     Source Type: Journal    
DOI: 10.1007/s13238-014-0024-5     Document Type: Letter

References (15)

1. Armstrong JA, Hart PD (1971) Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med 134: 713-740.
2. Balbi KJ, Rocha EP, Feil EJ (2009) The temporal dynamics of slightly deleterious mutations in Escherichia coli and Shigella spp. Mol Biol Evol 26: 345-355.
3. Ford CB, Lin PL, Chase MR, Shah RR, Iartchouk O, Galagan J, Mohaideen N, Ioerger TR, Sacchettini JC, Lipsitch M et al (2011) Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat Genet 43: 482-486.
4. Hershberg R, Lipatov M, Small PM, Sheffer H, Niemann S, Homolka S, Roach JC, Kremer K, Petrov DA, Feldman MW et al (2008) High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol 6: e311.
5. Keren I, Wu Y, Inocencio J, Mulcahy LR, Lewis K (2013) Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science 339: 1213-1216.
6. Kohanski MA, DePristo MA, Collins JJ (2010) Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol Cell 37: 311-320.
7. Kumar A, Farhana A, Guidry L, Saini V, Hondalus M, Steyn AJ (2011) Redox homeostasis in mycobacteria: the key to tuberculosis control? Expert Rev Mol Med 13: e39.
8. Little TJ, Allen JE, Babayan SA, Matthews KR, Colegrave N (2012) Harnessing evolutionary biology to combat infectious disease. Nat Med 18: 217-220.
9. Mestre O, Hurtado-Ortiz R, Dos Vultos T, Namouchi A, Cimino M, Pimentel M, Neyrolles O, Gicquel B (2013) High throughput phenotypic selection of Mycobacterium tuberculosis mutants with impaired resistance to reactive oxygen species identifies genes important for intracellular growth. PLoS One 8: e53486.
10. Podinovskaia M, Lee W, Caldwell S, Russell DG (2013) Infection of macrophages with Mycobacterium tuberculosis induces global modifications to phagosomal function. Cell Microbiol 15: 843-859.
11. Ramaswamy SV, Reich R, Dou S-J, Jasperse L, Pan X, Wanger A, Quitugua T, Graviss EA (2003) Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 47: 1241-1250.
12. Timmins GS, Deretic V (2006) Mechanisms of action of isoniazid. Mol Microbiol 62: 1220-1227.
13. Wang ZY, Xiong M, Fu LY, Zhang HY (2013) Oxidative DNA damage is important to the evolution of antibiotic resistance: evidence of mutation bias and its medicinal implications. J Biomol Struct Dyn 31: 729-733.
14. WHO (2010). Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. WHO/HTM/TB/20103.
15. Wilson LG (2005) Commentary: medicine, population, and tuberculosis. Int J Epidemiol 34: 521-524.